Price
$4.93-18.91%Social Signal Score
Analyst Ratings
13 analystsRevenue
$83.00M-42.76%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Claude LeBlanc
- Sector
- Financial Services
- Industry
- Insurance - Specialty
- Employees
- 483
- Beta
- 0.82
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- -0.01
Financials
Revenue
$83.00M-42.8%Net Income
$-14.43M-114.2%EBITDA
$3.37M-98.3%Free Cash Flow
$-10.23MEPS (diluted)
$-0.33-114.9%Shares Outstanding (diluted)
45.35M-1.0%Operating Expenses
$51.41MCash & Debt
$213.24MReturn of Capital
$4.86MRevenue by Segment (annual)
$52.84MQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $251.22M | $-240.92M | $-5.93 |
| 2024 | $235.81M | $-556.45M | $-11.85 |
| 2023 | $124.73M | $3.63M | $0.18 |
| 2022 | $53.61M | $521.25M | $11.48 |
| 2021 | $247.00M | $-17.00M | $-0.61 |
| 2020 | $156.00M | $-437.00M | $-9.47 |
| 2019 | $496.00M | $-216.00M | $-4.68 |
| 2018 | $508.00M | $267.00M | $4.07 |
| 2017 | $616.00M | $-329.00M | $-7.25 |
| 2016 | $501.93M | $74.84M | $1.66 |
| 2015 | $644.58M | $493.40M | $10.92 |
| 2014 | $403.39M | $484.07M | $10.73 |
| 2013 | $1.27B | $3.85B | $85.64 |
| 2012 | $863.27M | $-256.68M | $-2.74 |
Valuation
OSGhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50+66.67%Social Signal Score
Mentions (4)
- Newsbusinesswire.com·28d ago·Neutral
Octave Specialty Group Appoints Philip Stefano Head of Investor Relations NEW YORK--(BUSINESS WIRE)--Octave Specialty Group Appoints Philip Stefano Head of Investor Relations.
View source ↗ - Newszacks.com·56d ago·Neutral
OSG Q2 Earnings Miss Estimates, Revenues Beat on Distribution Growth OSG's Q2 revenues jumped 51% on strong Insurance Distribution growth and improving Everspan results, prompting a higher 2026 distribution outlook.
View source ↗ - Newszacks.com·56d ago·Neutral
OSG Q2 Earnings Call Focuses on MGA Growth and Mixed Guidance Octave Specialty Group raises 2026 Distribution growth and EBITDA guidance as MGA momentum accelerates, while cutting EPS and Everspan outlooks.
View source ↗ - Newsmarketbeat.com·58d ago·Negative
Octave Specialty Group Q2 Earnings Call Highlights Octave Specialty Group NYSE: OSG reported improved second-quarter results as growth in its Insurance Distribution segment and progress at its Everspan specialty insurance platform narrowed its net loss and lifted adjusted EBITDA.
View source ↗
Earnings
Mon, Nov 9(in 5 weeks)
Consensus estimate $-0.06 per share
Typical surprise +8.5% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 6$-0.04 vs $-0.01miss
- Wed, May 6$0.37 vs $0.02beat
- Mon, Feb 23$-0.02 vs $-0.21beat
- Mon, Nov 10$-0.21 vs $-0.23beat
- Thu, Aug 7$-0.22 vs $-0.24beat
- Mon, May 12$-0.13 vs $-0.07miss
Estimates and results for OSG via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by OSG officers and directors.
- Bought
- $305k
- Sold
- —
3 trades
0 trades
- Leblanc Claudebought
- Smith R Sharonbought
- Leblanc Claudebought
97 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in OSG.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.